p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

Circulation Research

Volumn 80, Issue 1, 1997, Pages 45-51

  Fukui, Toshiki ^d   Ishizaka, Nobukazu ^d   Rajagopalan, Sanjay ^d   Laursen, Jørn Bech ^b   Capers IV, Quinn ^d   Taylor, W Robert ^a   Harrison, David G ^a   De Leon, Hector ^d   Wilcox, Josiah N ^d   Griendling, Kathy K ^c  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b Rigshospitalet   (Denmark)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

angiotensin II; hypertension; muscle, smooth, vascular; NADPH oxidase; p22phox

Indexed keywords

ANGIOTENSIN; CYTOCHROME B; HYDRALAZINE; LOSARTAN; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HYPERTENSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

EID: 0031015288     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.1.45     Document Type: Article

References (25)

1. Alexander RW, Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response. Hypertension. 1995;25:155-161.
2. Ohara Y, Peterson TE, Harrison DG, Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91: 2546-2551.
3. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A, 1991;88:10045-10048.
4. Matsubara T, Ziff M. Increase superoxide anion release from human endothelial cells in response to cytokines, J Immunol. 1986;137: 3295-3298.
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
6. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Haberniehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem J. 1989; 263:539-545.
7. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18:132-141.
8. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol. 1994;267:L815-L822.
9. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH osidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995;268:H2274-H2280.
10. Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22-phox). J Clin Invest. 1990; 86:1729-1737.
11. Fukui T, Lassègue B, Kai H, Alexander RW, Griendling KK. Cytochrome b-558 α-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta, 1995;1231:215-219.
12. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/ NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317- 23321.
13. Jones SA, Hancock JT, Jones OTG, Neubauer A, Topley N. The expression of NADPH oxidase components in human glomerular cells: detection of protein and mRNA for p47-phox, p67-phox, and p22-phox, J Am Soc Nephrol. 1995;5:1483-1491.
14. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA. Griendling KK, Harrison DG, Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation: contribution to alterations of vasomotor tone, J Clin Invest. 1996;97:1916-1923.
15. Wilcox JN. Fundamental principles of in situ hybridization. J Histochem Cytochem. 1993;41;1725-1733.
16. Radeke HH, Cross AR, Hancock JT, Jones OTG, Nakamura M, Kaever V, Resch K. Functional expression of NADPH oxidase components (α- and β-subunits of cytochrome b558 and 45-KDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem. 1991;266:21025-21029.
17. Bauldry SA, Elsey KL, Bass DA. Activation of NADPH oxidase and phospholipase D in permeabilized human neutrophils. J Biol Chem. 1992;267:25141-25152.
18. Mügge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293-1300.
19. Wolin MS. Activated oxygen metabolites as regulators of vascular tone. Klin Wochenschr, 1991;69:1046-1049.
20. Meier B, Jesatis AJ, Emmendorffer A, Roesler J, Quinn MT. The cytochrome b-558 molecules involved in the fibroblast and polymorphonucleur leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct Biochem J. 1993;289:481-486.
21. Jones SA, Wood JD, Coffey MJ, Jones OTG. The functional expression of p47-phox and p67-phox may contribute to the generation of Superoxide by an NADPH oxidase-like system in human fibroblasts. FEBS Lett. 1994;355:178-182.
22. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature. 1987;327:717-720.
23. Munzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WA, Thompson JA, Freeman B, Harrison DG. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest. 1996;6:1465-1470.
24. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT: Multiple Risk Factor Intervention Trial. Am Heart J. 1986; 112:825-836.
25. Cassatella MA, Bazzoni F, Flynn RM, Dusi S, Trinchiere G, Rossi F. Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability. J Biol Chem. 1990; 265:20241-20246.